Tailored eculizumab regimen for patients with atypical hemolytic uremic syndrome: requirement for comprehensive complement analysis
Gespeichert in:
| Hauptverfasser: | , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
[2014]
|
| In: |
Journal of thrombosis and haemostasis
Year: 2014, Jahrgang: 12, Heft: 9, Pages: 1437-1439 |
| ISSN: | 1538-7836 |
| DOI: | 10.1111/jth.12639 |
| Online-Zugang: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1111/jth.12639 Verlag, lizenzpflichtig, Volltext: https://onlinelibrary.wiley.com/doi/abs/10.1111/jth.12639 
|
| Verfasserangaben: | C. Wehling and M. Kirschfink (Institute of Immunology, University of Heidelberg) |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1728909996 | ||
| 003 | DE-627 | ||
| 005 | 20220818191958.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 200904s2014 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1111/jth.12639 |2 doi | |
| 035 | |a (DE-627)1728909996 | ||
| 035 | |a (DE-599)KXP1728909996 | ||
| 035 | |a (OCoLC)1341358537 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Wehling, Cyrill |d 1989- |e VerfasserIn |0 (DE-588)1136431187 |0 (DE-627)892909331 |0 (DE-576)490527817 |4 aut | |
| 245 | 1 | 0 | |a Tailored eculizumab regimen for patients with atypical hemolytic uremic syndrome |b requirement for comprehensive complement analysis |c C. Wehling and M. Kirschfink (Institute of Immunology, University of Heidelberg) |
| 264 | 1 | |c [2014] | |
| 300 | |a 3 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 04.09.2020 | ||
| 700 | 1 | |a Kirschfink, Michael |e VerfasserIn |0 (DE-588)120927152 |0 (DE-627)080974457 |0 (DE-576)292452411 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Journal of thrombosis and haemostasis |d [Amsterdam] : Elsevier, 2003 |g 12(2014), 9, Seite 1437-1439 |h Online-Ressource |w (DE-627)361297211 |w (DE-600)2099291-9 |w (DE-576)103373810 |x 1538-7836 |7 nnas |a Tailored eculizumab regimen for patients with atypical hemolytic uremic syndrome requirement for comprehensive complement analysis |
| 773 | 1 | 8 | |g volume:12 |g year:2014 |g number:9 |g pages:1437-1439 |g extent:3 |a Tailored eculizumab regimen for patients with atypical hemolytic uremic syndrome requirement for comprehensive complement analysis |
| 856 | 4 | 0 | |u https://doi.org/10.1111/jth.12639 |x Verlag |x Resolving-System |z lizenzpflichtig |3 Volltext |
| 856 | 4 | 0 | |u https://onlinelibrary.wiley.com/doi/abs/10.1111/jth.12639 |x Verlag |z lizenzpflichtig |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20200904 | ||
| 993 | |a Article | ||
| 994 | |a 2014 | ||
| 998 | |g 120927152 |a Kirschfink, Michael |m 120927152:Kirschfink, Michael |d 910000 |d 911600 |e 910000PK120927152 |e 911600PK120927152 |k 0/910000/ |k 1/910000/911600/ |p 2 |y j | ||
| 998 | |g 1136431187 |a Wehling, Cyrill |m 1136431187:Wehling, Cyrill |d 50000 |e 50000PW1136431187 |k 0/50000/ |p 1 |x j | ||
| 999 | |a KXP-PPN1728909996 |e 3746756022 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"language":["eng"],"id":{"doi":["10.1111/jth.12639"],"eki":["1728909996"]},"type":{"bibl":"article-journal","media":"Online-Ressource"},"origin":[{"dateIssuedKey":"2014","dateIssuedDisp":"[2014]"}],"relHost":[{"type":{"bibl":"periodical","media":"Online-Ressource"},"id":{"doi":["10.1111/(ISSN)1538-7836"],"eki":["361297211"],"issn":["1538-7836"],"zdb":["2099291-9"]},"language":["eng"],"corporate":[{"display":"International Society on Thrombosis and Haemostasis","role":"isb"}],"part":{"text":"12(2014), 9, Seite 1437-1439","pages":"1437-1439","volume":"12","issue":"9","extent":"3","year":"2014"},"titleAlt":[{"title":"jth"}],"title":[{"title_sort":"Journal of thrombosis and haemostasis","title":"Journal of thrombosis and haemostasis","subtitle":"the official journal of the International Society on Thrombosis and Haemostasis"}],"physDesc":[{"extent":"Online-Ressource"}],"origin":[{"dateIssuedKey":"2003","publisher":"Elsevier ; Blackwell Publishing ; Wiley-Blackwell","dateIssuedDisp":"2003-","publisherPlace":"[Amsterdam] ; Oxford ; Oxford"}],"note":["Gesehen am 16.02.2023"],"pubHistory":["1.2003 -"],"recId":"361297211","disp":"Tailored eculizumab regimen for patients with atypical hemolytic uremic syndrome requirement for comprehensive complement analysisJournal of thrombosis and haemostasis"}],"person":[{"given":"Cyrill","display":"Wehling, Cyrill","family":"Wehling","role":"aut"},{"given":"Michael","display":"Kirschfink, Michael","family":"Kirschfink","role":"aut"}],"title":[{"title_sort":"Tailored eculizumab regimen for patients with atypical hemolytic uremic syndrome","subtitle":"requirement for comprehensive complement analysis","title":"Tailored eculizumab regimen for patients with atypical hemolytic uremic syndrome"}],"physDesc":[{"extent":"3 S."}],"recId":"1728909996","note":["Gesehen am 04.09.2020"],"name":{"displayForm":["C. Wehling and M. Kirschfink (Institute of Immunology, University of Heidelberg)"]}} | ||
| SRT | |a WEHLINGCYRTAILOREDEC2014 | ||